Main > ONCOLOGY (**) > Skin Cancer>Merkel Cell C.>MET *** > Treatment > USA. M. PembrolizuMAb Inj.

---

USA. M. PembrolizuMAb Inj.'s subsections
(*) USA Approval Date: 2018. 12.19.
Company
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 5
Patent>UpDate: 2019. 12.31.
TradeMark
TradeMark Web-Site

USA. M. PembrolizuMAb Inj.'s products
This section has no products